hospitals a health afternoon. its freezes and XXXX ongoing full Good requirements, mostly elongated capital year that to sales We and found resulting budget Scott. approval you, Thank capital point-of-care the XXXX the reacted company was for This year resulted lowering our business challenges and in macroeconomic challenging the additional guidance. many in company. impacted cycles. by implementing systems
that we in pleased seen not so quarter further am environment in healthcare the far have and in last I to note XXXX. XXXX of deterioration the
that XXXX, quarter ranges. generally revised delivered XXXX fourth results exceeded we For our guidance
the on relationships customers an them retail Omnicell healthcare in-patient in long-term investments vision build pharmacy. of care, rely realize to deliver effort continue help and pharmacy on improvements and industry strategic look autonomous with return to achieve Our partner to system to to the and
to fourth XXXX quarter earnings guidance our posted year Investor top full and GAAP our in $XXX Our our GAAP million our or quarter reconciliation revised on above $X the website. fourth end press release range. is Relations revenues and is A were of and million included XXXX of results non-GAAP non-GAAP full XXXX
impact well our we efforts of as right-of-use the office assets loss the in impact fourth per of hybrid fourth of November with fourth in were $XX includes The to lease accordance align GAAP for strategy. as earnings income share $X.XX share, the the per of quarter space as expenses quarter part $X work of our million with as XXXX quarter share on in XXXX, disclosed the in we quarter Form per X-K broader for previous of of operating GAAP earnings share impairment share $X.XX the $X.XX per XXXX. XX, million accordance in per rationalized a as of to filed compared with and the XXXX Our income severance-related
of Cost quarter previous XXXX XXXX announced fourth the previously quarter a very in actions, results. to of impact lower on the fourth points November the revenue for volume margin including quarter had primarily decrease was basis due gross headcount XX.X%, generally reductions XXX Non-GAAP the XXXX from little leverage.
to margin more from these gross the begin to expect We in and XXXX. the on operating fully of expenses second actions see benefit quarter
to volume fourth the projected of by beginning return grow We the see leverage is the as quarter revenue expect year. to to throughout XXXX
previous the in in and million $XX to last period compared $XX same million, year. $XX million quarter was EBITDA non-GAAP quarter Fourth the
quarter Fourth same share quarter compared earnings last per share per per the expense of lower previous $X.XX quarter earnings share our in non-GAAP share lower $X.XX period and XXXX above sales, year. cost compensation. quarter due the Fourth were revenue, non-GAAP performance-based in XXth higher share, to per guidance to and per management XXXX solid were $X
offset freezes a increase primarily review requirements, Services XXXX increasing an CapEx, year Advanced in Turning health were our for XXXX. compared $X.XXX bookings billion, budget XX% now decreased partially the approval an bookings due year full additional slowdown as full CapEx or systems, results, for number in the billion Bookings to to point-of-care prior bookings. XXXX year, implemented full $X.XXX over of year to by
was to XXXX. $X.XXX as XX, as December backlog XX, of total of Our billion compared billion XXXX, $X.XXX December
on Relations detail Investor Form and our further X-K in website prior today presentation, earnings the our call. slide filed of to based all As today’s XX on we
backlog bookings. information the our additional of Advanced about and Services providing now both are derived portion products We from
Backlog to Services, expected represents that in recognized bookings the backlog to XX be and not dollar products for yet as our be backlog. revenue. revenues amount converted long-term which has more We than of consider been Advanced to months is
devices, Product service portion our compounding and such dispensing dispense of our service. XT the and backlog IT includes as pharmacy, systems product central connected Series automated
and is million believe of the as $XXX the was $XXX backlog. will $XX We convertible long-term of backlog months. majority between revenues XX, and Product months product into be product million, million backlog short-term of is product long-term backlog XX XXXX, XX December which
within and a backlog our such XXXB Services the solutions, as solutions, our Services IV inventory our as Pharmacy Solutions, agreement. portion have software only includes EnlivenHealth services and the minimum multiyear compounding as portion central which the Services Advanced service Advanced of pharmacy service. commitment service of Services, optimization Specialty dispense include contracts, service stated Advanced well other
are Services our of stated commitments. and when minimum Advanced partner closely on provided Advanced providing Services our the contracts portion While we Only majority a with the of contracts. customers these has multiyear
commitments contractual was of Services backlog Advanced long-term consisting of is Services backlog, $XXX $XX which backlog. and $XXX as is Advanced million, XX, short-term Services million December XXXX, million Advanced of minimum
represents Long-term terms seven Advanced agreements Services of backlog between two usually multiyear years years. contractual typically the and subscription
which have revenue term. to yet converted will be the of which Some contractual not been ratably implemented, over
challenging macroeconomic a our billion record the year a Despite GAAP XXXX revenues were $X.XXX were and non-GAAP environment, revenues full $X.XXX billion. record
saw The well adherence million and the as of strong XX% recent non-GAAP management of impact scaling revenue reflects revenue XXXX. $XXX for automation XXXX increase an revenue medication continued of demand as Our solutions Advanced year-over-year acquisitions. or contribution the from Omnicell non-GAAP Services from and increase
with per Our GAAP were in $X.XX full year share XXXX share. earnings accordance per
driven from share, year-over-year originally expected from mostly of XX% XXXX. a full reduced second XXXX operating earnings than half per year or per revenue the Our The XXXX. per were $X of was share $X.XX by leverage during decrease lower decrease non-GAAP share
inflationary were primarily freight than cost at For full million $XX to the steel moderation earnings million, expected semiconductor due is XXXX year in inflation. XXXX, third total costs quarter call, $X of which and the lower time
EBITDA full $XXX year. decrease XXXX our EBITDA non-GAAP XXX non-GAAP the above year million, is previous margin points For revised Full basis year guidance a which we from was delivered range. of of of XX% XXXX, XXXX
of the inventory moving free a well cash lower higher XXXX flow, Now flow decrease due and of net is $XXX GAAP collections. to of million full primarily timing cash of cash million, income, as to as $XX impact year
to $XXX The of the end XXXX. of was fourth cash flow as up the September XXXX, free cash XX, result cash strong and is increase from balance of $XXX our quarter million million million, of At $XX in record the the in quarter was fourth previous million of the in compared cash from the quarter quarter $X $XX $XX cash XXXX. the million, fourth million of during XXXX collections of quarter XXXX. and Free fourth flow
fourth accounts was previous quarter the outstanding sales days unchanged the XX for of In receivables, from terms days, of XXXX quarter.
lines. million Inventories XXXX. million, and includes December XXXX, approximately note as $X as XXXX, important supply quarter million XX, to were of of receipts that help inventories from $XXX from of future that time of quarter we fourth of the semiconductors million implementation the XX, of the increase of an prior It will reasonably purchases secure December $X increase believe is for $XX an expense and customer
be for becoming demand to balanced, particularly While times The execute supply more to long. we and to teams well in continue lead point-of-care. semiconductors volumes, continue adjust are as revise revenue
of and We on level including to continue products our confidence a to mission-critical chain systems for components with devices our to that and semiconductors customers. expect connected continue supply will critical to our healthcare high has deliver procure
billion. the bookings. approximately be XXXX the equal to midpoint Advanced on both concern bookings full expect includes XXXX $X.X bookings Bookings XXXX continued XXXX as as the guidance the bookings year and our and to of our bookings Now full products, moving The on from quarter the marketing from Services. well year is guidance, team, given first we to $X XXXX billion between
total For $X.XXX between full year revenues XXXX, we to billion. billion expect and be $X.XXX
revenue million product expect for and year $XXX short-term consisting lesser to between extent, revenue range million, revenue backlog revenue. to of $XXX and from expected from a consumables recurring product bookings within We
million. be between expect We to revenues $XXX $XXX million service and XXXX
well as as revenue from services. Our Services, service Advanced both includes revenue technical revenue from
be million, service XXXX between a which $XXX We of and Services increase at million the approximately from expect XX% compared XX% revenue is represents XXXX revenue to $XXX Advanced midpoint to revenues. and
extent, the the expected revenue solutions of Advanced a services new consists of revenue Services from and base revenue Services Advanced to implementations. short-term Advanced of the and lesser backlog Services installed recurring XXXX expected The and
training services, summary our revenue guidance of customer website Investor compared education million our includes We components. XX revenue increase slide our solutions expect in to see $XXX support, the post-installation Relations and for technical which service between a published on technical million X% presentation and range XXXX. in Please to for $XXX as number earnings of an XXXX,
announced effort XXXX containment revenue November Today, reduction with part in as with operating force cost and cost of an also announced a align volume. in expected actions our leverage containment measures, we we our the in create to together cost
today’s total functions reduction reduction half reduced as mostly was as November, the well in sales, Of of in included in volume. announcement, headcount cost of announced within force from the approximately
are reduction that continue of that forward, key investments portion force to as in very went in drive expected the Of in SG&A expenses to reduce will R&D us going operating all we innovation. of make functions nearly included with little
We expect these expected increased actions expected second impact as the as moderating actions, inflationary pricing containment volume XXXX costs. to to of from and gross margin in modestly of well the benefits due percentage cost half leverage, expand
to and innovation, specifically balance Services cost seek automation strategic including continue containment to We next-generation solutions. Advanced with and investing
million reductions A to other annual majority in is expense $XX expense savings of SG&A. in anticipated from from the and derived be of expected included operating recent functions approximately the containment efforts force
The offset in expected year-over-year investments in cost operating performance R&D. and inflation the and employee impact expense find by expected of the savings salaries be in compensation will largely XXXX annual increases increases based
expect in operating in reflects -- flat continuing our down in on by total R&D, by non-GAAP increase SG&A to while agenda. investments our offset slightly savings with cost expenses We focus be which growth non-GAAP non-GAAP slightly an year-over-year
from to recent put pressures impact which greater pricing to reduce in favorable expect expect million and and volume, includes revenue estimated guidance We non-GAAP total $XXX the total to year to non-GAAP between EBITDA expect in we actions in inflationary XXXX. lower XXXX from year we leverage, and impact million. be a cost the operating impact have years $XXX XXXX actions EBITDA create designed anticipated The place
within as the and the timing the in second impact through We pricing projected based the leverage expenses cost of margins margin of actions, year. and half EBITDA actions on of expect operating volume move gross we XXXX to expand
We tax lower count under employee XXXX issued in and our earnings of per blended between XXXX to the This share a $X.XX a non-GAAP share. per rate takes being $X.XX and plans. account shares as expect be new in share stock expected into increase expected result
of are year tax to assuming guidance, our we actual XXXX. share of XXXX, in an per For full in tax blended effective compared rate non-GAAP an blended earnings rate approximately X% X%
guidance. quarter the are the For first we XXXX, following providing of
and million million between million. We between to be between revenues $XXX to expect $XX $XXX million and total million first XXXX $XX million, $XXX with revenues $XXX quarter and product to revenues and be be service
quarter And to between first between be be non-GAAP and share expect non-GAAP EBITDA to $X.XX first share. expect million XXXX XXXX per $X We $X.XX per quarter $XX per million. we earnings share and
strength in We seeing agreements partnerships, have in health the customers our source sole the U.S. with long-term customer Services. Of of systems. than of XXX U.S. our least XXX over our for XXX systems, more top contracted half which include top health one are Advanced at
we see of scaling, As adoption XXX strong Advanced momentum U.S. within to the systems. our Advanced in health continue Services are to the Services expand top pipeline the
We in look We potential our environment stakeholders in value for strive long-term in we to opportunities. our continue all macroeconomic this forward deliver confident our quarters. the progress of and coming to remain you to challenging on updating
make great team, to company. with words Randall our Directors of want have worked incredible great earlier all people call. and leadership has been a Omnicell in thank the kind privilege I Lastly, It executive the who a of our you, Board your to for
chain, a played led development model the during supply created such have I of part being to and within scaling grateful that part am of has global have time IT of team healthcare. a the and teams am business value and finance, international, transformation. the proud I corporate
in the when be successor have have career. ago commences I will the chapter achieve next are over as I for the will to the Omnicell help year. looking my I objectives out smooth to years I transition point, joined forward team and in supporting we this assist I At to accomplished later this and search seven set my a
is automation full management take very evolve positioned will success. medication to well know and great need to and always wish for I the I continue advantage company solutions the Omnicell of that
the open for With questions. would like to that, your call we